Hannah Hazard-Jenkins, M.D., associate chair of surgery for cancer services, has been named interim director of the WVU Cancer Institute, effective January 2020. [...]
The WVU Cancer Institute will begin enrolling its first patients in a National Institute of Health (NIH) Beau Biden Moonshot Initiative trial on Oct. 25 as part of a consortium of six U.S. healthcare [...]
For some cancer patients, having inoperable or at least risky-to-treat tumors doesn’t necessarily mean they’re untreatable if the right technology is applied. [...]



WVU Medicine © 2016